Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Alteogen disclosed that the 100% payment for its previously resolved third-party allotment paid-in capital increase (redeemable convertible preferred stocks) worth KRW 155.00B has been successfully completed.
📊 [Key Disclosure Details & Financial Highlights]
- Type of Securities: Registered Redeemable Convertible Preferred Shares (RCPS)
- Method of Issuance: Third-party allotment paid-in capital increase
- Issuance Details:
- Actual Number of Shares Issued: 434,848 shares (Same as scheduled)
- Actual Amount Raised: KRW 154,994,177,184 (Approx. KRW 155.00B, Same as scheduled)
- Payment Date: 2025-02-19
- Initial Board Resolution Date: 2025-02-04
- Scheduled Listing: No (Unlisted)
- Key Schedules & Terms:
- Scheduled New Share Delivery Date: 2025-03-05
- Issued RCPS will be placed under mandatory lock-up with the Korea Securities Depository for 1 year from the delivery date
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Delivery of New Shares and Mandatory Lock-up Reflection in Official Reports
This filing confirms the full settlement of the KRW 155.00B capital raise previously resolved by the board. Verifying whether the delivery of new shares and the 1-year mandatory lock-up registration are finalized on the target date (March 5, 2025) is important to track changes in total outstanding shares and capital structure. Final confirmation can be reviewed in the ‘Total Number of Shares’ and ‘Notes to Financial Statements’ sections of upcoming quarterly, half-yearly, or annual reports.
📢 Disclaimer & Source Information
Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For inquiries regarding regulatory compliance or copyright requests, please contact ksb220805@gmail.com.
